Latest News
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Through RETHINKING Alzheimer’s disease (AD), the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are joining forces with the ambition of improving Alzheimer’s disease care pathway and the lives of people living with it. Officially launched on 29 April 2022, the project kicked off its operational activities with the aim to call for [...]
German Brain Council presents “German Brain Plan – Agenda 2030”
The German Brain Council was pleased to present "German Brain Plan - Agenda 2030" at the 8th Academy of National Brain Councils. The event, organised by the European Brain Council, took place on 10th May 2022 and was hosted at the Representation of the Free State of Bavaria to the European Union in Brussels, Belgium. Five examples covering the [...]
Visit the extended exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU”
On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition "Living with MS during COVID-19: A case for rethinking MS care in the EU" brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level. Impact of the COVID-19 pandemic on multiple sclerosis at national level The COVID-19 pandemic [...]
EBRA launches open consultation on Shared European Brain Research Agenda
The preparation of the Shared European Brain Research Agenda (SEBRA) is currently underway within the EBC-coordinated European Brain Research Area (EBRA) project, with the aim to provide recommendations on future areas for excellent, innovative, and translational research. Existing strategic research agendas have been taken into consideration and input has been collected from a first set of identified experts in the European brain research area. A Consultation is now open on this first draft [...]
EBC celebrates 20 years!
Twenty years ago to this day, the European Brain Council (EBC) was formed. The brain child of Prof. Jes Olesen, EBC was the answer to the need for increased unity within the brain community, building a more connected network of key players in the brain space — scientists, clinicians, patients, industry — encompassing basic neuroscience, neurology, neurosurgery and psychiatry. [...]
A look back at Brain Awareness Week 2022
Brain Awareness Week 2022 was a busy time period for EBC this year, with a series of virtual launches taking place, namely the release of the 2nd Round of the Value of Treatment project results and Calls to Action as well as the Save the Date for two major events later this year. On Monday, 14 March, the Value of [...]
Save the Date for the EBRA Final Conference & Brain Innovation Days 2022
The EBC-coordinated European Brain Research Area (EBRA) project is in its final months and today launches a Save the Date for its Final Conference, to be held in conjunction with the Brain Innovation Days, which will be back this year with its annual in-person event. The events will take place in Brussels, Belgium on 11 and 12 October 2022. The [...]
Value of Treatment project releases results and calls to action on the occasion of Brain Awareness Week 2022
On the occasion of Brain Awareness Week 2022, the EBC-led Value of Treatment project – currently in its second round – releases results and calls to action this week. The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project launched in 2015, with the objective to identify treatment gaps (or barriers to care) [...]
EBRA releases Mapping Report: investment in European brain research still vital
9 February 2022 The EU-funded European Brain Research Area project today releases its long-awaited European Research Inventory and Mapping Report, providing insight into the brain research activities funded at the European level within the EU framework programmes FP7 and Horizon 2020, as well as the funding initiatives of the EU Joint Programme – Neurodegenerative Disease Research (JPND), ERA-NET NEURON [...]
Event report | Best practices for patient safety: An EU-wide view on the use of medicines off-label
On 30 November, the GOLUP consortium held a virtual event, led by the European Brain Council, to build on the latest discussions on the Declaration on Good Off-Label Use Practices. The event was hosted by MEP Cyrus Engerer (S&D, Malta), who is a member of the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI). . The conversation involved all [...]